Cargando…

BETting on a new prostate cancer treatment

Detalles Bibliográficos
Autores principales:	Asangani, Irfan A, Chinnaiyan, Arul M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Landes Bioscience 2014
Materias:	Editorials: Cell Cycle Features
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4111688/ https://www.ncbi.nlm.nih.gov/pubmed/24905827 http://dx.doi.org/10.4161/cc.29459

Ejemplares similares

BRD4: A BET(ter) target for the treatment of AML?
por: Valent, Peter, et al.
Publicado: (2014)

To target or not to target the enemy within localized prostate cancer
por: Risbridger, Gail, et al.
Publicado: (2013)

Revealing targeted therapeutic opportunities in triple-negative breast cancers: A new strategy
por: Poage, Graham M, et al.
Publicado: (2013)

New roles of Rb1 in expansion of MDSCs in cancer
por: Youn, Je-In, et al.
Publicado: (2013)

A new BET on the control of HIV latency
por: Karn, Jonathan
Publicado: (2013)

Prolyl isomerization: A new PIN code for DSB repair
por: Sartori, Alessandro A, et al.
Publicado: (2013)

The weakest link: A new paradigm for stabilizing the integrin–actin connection
por: Morgner, Jessica, et al.
Publicado: (2013)

CDK5: A new lead to survival
por: Lew, John
Publicado: (2013)

A new development in DNA repair modulation: Discovery of a BLM helicase inhibitor
por: Banerjee, Taraswi, et al.
Publicado: (2013)

N-cadherin: A new player in neuronal polarity
por: Gärtner, Annette, et al.
Publicado: (2012)

F-box protein substrate recognition: A new insight
por: Chen, Bill B., et al.
Publicado: (2013)

The chains of death: A new view on caspase-8 activation at the DISC
por: Schleich, Kolja, et al.
Publicado: (2013)

A new path to oncogene-induced senescence: At the crossroads of splicing and translation
por: Das, Shipra, et al.
Publicado: (2013)

DNA2, a new player in telomere maintenance and tumor suppression
por: Chai, Weihang, et al.
Publicado: (2013)

A new signaling paradigm to control the prenylation and trafficking of small GTPases
por: Williams, Carol L
Publicado: (2013)

EXD2 - a new player joins the DSB resection team
por: Nieminuszczy, Jadwiga, et al.
Publicado: (2016)

Stat3 in mitosis: A new role in clustering excess centrosomes
por: Morris, Edward J., et al.
Publicado: (2017)

Two new kinases in the TOR signaling network regulate ribosome and tRNA synthesis
por: Willis, Ian M., et al.
Publicado: (2012)

Adding a new facet to STAT5 in CML: Multitasking for leukemic cells
por: Warsch, Wolfgang, et al.
Publicado: (2013)

“Take it up a NOTCH: ” Novel strategies for cancer therapy
por: Morgan, Stefanie L., et al.
Publicado: (2013)

The decapping scavenger enzyme DCS-1: A new modulator of miRNA turnover
por: Meziane, Oussama, et al.
Publicado: (2013)

FACT and H3.3: New markers for the somatic hypermutation
por: Aida, Masatoshi, et al.
Publicado: (2013)

eIF4E3, a new actor in mRNA metabolism and tumor suppression
por: Volpon, Laurent, et al.
Publicado: (2013)

New epigenetic pathway for stemness maintenance mediated by the histone methyltransferase Ezh1
por: Hidalgo, Isabel, et al.
Publicado: (2013)

The ORC/Cdc6/MCM2–7 complex, a new power player for regulated helicase loading
por: Riera, Alberto, et al.
Publicado: (2013)

Cancer-associated chromosomal deletions: Size makes a difference
por: Cai, Yanyan, et al.
Publicado: (2016)

Transactivation by low and high levels of human p53 reveals new physical rules of engagement and novel super-transactivation sequences
por: Menendez, Daniel, et al.
Publicado: (2012)

Targeting the Achilles’ heel of drug-resistant cancer stem cells
por: Seguin, Laetitia, et al.
Publicado: (2014)

Vaccines and early breast cancer
por: Caballero, Otavia L, et al.
Publicado: (2014)

DEC1 and MIC-1: New players of p53-dependent cell fate decision
por: Qian, Yingjuan, et al.
Publicado: (2012)

Lineage progression from stem cells to new neurons in the adult brain ventricular-subventricular zone
por: Ponti, Giovanna, et al.
Publicado: (2013)

TLS/FUS: A protein in cancer and ALS
por: Tan, Adelene Y., et al.
Publicado: (2012)

Pancreatic cancers rely on a novel glutamine metabolism pathway to maintain redox balance
por: Lyssiotis, Costas A., et al.
Publicado: (2013)

The FAT epidemic: A gene family frequently mutated across multiple human cancer types
por: Morris, Luc G.T., et al.
Publicado: (2013)

The metabolic facet of pancreatic cancer: How hypoxia shapes fatal cancer cells
por: Guillaumond, Fabienne, et al.
Publicado: (2013)

IF1 reprograms energy metabolism and signals the oncogenic phenotype in cancer
por: Sánchez-Aragó, María, et al.
Publicado: (2012)

“Sister” miRNAs in cancers
por: Wahdan-Alaswad, Reema, et al.
Publicado: (2013)

Too much or too little: Harnessing senescence to control oncogene-driven cancer
por: Hannan, Katherine M., et al.
Publicado: (2012)

Skp2: A dream target in the coming age of cancer therapy
por: Chan, Chia-Hsin, et al.
Publicado: (2014)

miR-34a/SIRT6 in squamous differentiation and cancer
por: Dotto, G Paolo, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_plhr0tejt7ohvg07fvj4jrtk6t